Safety and efficacy of semaglutide for non-alcoholic fatty liver disease: A meta-analysis of clinical outcomes
Muhammad Shaheer Bin Faheem(King Edward Medical University), Aymar Akilimali(Roslin Institute), Nadeem Ahmad(Khyber Medical College), Muhammad Usman(Dow University of Health Sciences), Amna Anwar(Federal Medical Centre), Jabez David John(Malla Reddy Institute Of Medical Sciences), Haniya Shahid(Shaheed Mohtarma Benazir Bhutto Medical University), Iqra Mazhar(Shaukat Khanum Memorial Cancer Hospital and Research Center), Muhammad Rafay-ur-Rehman, Shamikha Cheema(King Edward Medical University), Calvin R. Wei, Razia Sultana(Lincoln University College), Muhammad Saheer Bin Faheem(King Edward Medical University), Mohamed Rifai(Menoufia University), Farman Ullah Khan(Ayub Medical College), Kanza Farhan(Jinnah Sindh Medical University), Faiza Fatima(Services Institute of Medical Sciences)
Cited by 0
Related Papers
Patient Phenotype Profiling in Heart Failure with Preserved Ejection Fraction to Guide Therapeutic Decision Making. A Scientific Statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension
|European Journal of Heart Failure|2023|187
Efficacy and Safety of SGLT2 Inhibitors in Heart Failure: Systematic Review and Meta-Analysis
|ESC Heart Failure|2020|141
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29